Welcome to this week’s AI round-up! In this edition, we cover Claude Mythos Preview’s 100% pass rate on a cybersecurity benchmark that Anthropic has already declared saturated, new research on AI in legal practice, two policy briefs on AI occupational exposure and Europe’s semiconductor position, and three startups raising rounds across hospital infection control, consumer goods compliance, and preventive health.
This week at a glance:
Cybench, a yardstick AI outgrew: Claude Mythos Preview has solved every task on the Cybench benchmark at first attempt, two years after GPT-4o managed 12.5%, on a benchmark Anthropic’s own system card had already declared no longer useful for tracking capability progression.
Three policy briefs on AI exposure and European chips: an OECD capability index remaps occupational automation risk, a Bruegel analysis questions whether Europe's hardware advantage is structural or contingent, and a Microsoft Institute report finds Norway, Ireland, and France each outpacing the United States on AI adoption as a share of working-age adults.
Legal AI past the productivity question: five studies confirm productivity gains of 38% to 140% in legal tasks, while also finding residual hallucination rates in validated vendor tools, measurable bias amplification in predictive systems, and a regulatory framework that addresses the technology one step downstream of where it is being deployed.
Startup spotlights: NEX Health Intelligence, Certo, and Lucis each closed rounds this week across hospital infection prevention, consumer goods regulatory compliance, and preventive blood biomarker analysis.
Cybench went from 12.5% to 100% in two years. Claude Mythos Preview solves every adversarial cybersecurity task at first attempt, tasks that took human expert teams nearly 25 hours, after the Opus 4.x line crossed the 60s, 70s, and 90s in successive releases. Anthropic had already declared the benchmark saturated and gated Mythos behind Project Glasswing. The eval outlived its usefulness just as the capability crossed into territory that matters.
→ Read the full analysis at AI World
The OECD’s new AI Capability Gap Index ranks billing clerks and typists as the most exposed occupations, not actuaries or mathematicians, because full occupational profiles include social judgement that current systems do not reach. Bruegel flags the same structural risk in European chip strategy: an industrial consortium built on national allocation rather than comparative advantage repeats the fragmentation problem.
A Microsoft Institute report adds the sharpest corrective: Norway, Ireland, and France each outpace the United States on AI adoption as a share of working-age adults, with the US ranking 21st globally at 31.9%.
→ Read the full analysis on AI World Linkedin page
This week's selection traces two converging lines: the empirical record on AI in legal practice, from randomised trials through vendor evaluation to distributional effects, and the governance gap between where the EU AI Act draws its high-risk boundary and where legal AI is actually being deployed.
→ Read the full paper summaries on AI World
This week’s selection explores the use of AI in addressing structural gaps in hospital infection control, consumer goods regulatory compliance and preventive health monitoring.
🇬🇧 NEX Health Intelligence: UK-based, co-founded by Dr Ashleigh Myall and Dr Chang Ho Yoon. NEX has built an AI platform for infection prevention and control that operates across risk intelligence, outbreak detection, and automated case review surveillance, integrating with existing hospital infrastructure and compliant with NHS DTAC and related standards. Raised €1 million in a pre-seed round led by Brighteye Ventures, May 2026.
🇫🇷 Certo: Paris-based, co-founded by Bastien Deliège-Coste and Jean Duquenne. Certo's domain-specific AI agents cross-reference cosmetic and consumer goods products against a proprietary regulatory database covering the EU, US, China, South Korea, Japan, and Latin America, with five modules covering the full compliance process - from ingredient approval to market entry documentation. Raised $4 million in a seed round led by Daphni, with Entrepreneurs First, Motier Ventures, and Transpose Platform participating, May 2026.
🇫🇷 Lucis: Paris-based, founded 2025 by Maxime Berthelot and Baptiste Debever. Lucis analyses more than 110 blood biomarkers through a network of over 400 certified partner laboratories across France, the UK, Ireland, and Portugal, delivering AI-powered personalised health guidance reviewed by healthcare professionals, with longitudinal retesting compounding the precision of recommendations over time. Raised $20 million in a Series A led by Singular, with General Catalyst and Y Combinator participating, bringing total funding to $28 million.
For more updates, research and insights across the AI ecosystem, visit aiworld.eu. Subscribe to receive next week’s round-up directly in your inbox and stay ahead of key developments.
Have a great weekend!
Gaia Cavaglioni
On behalf of the AI World Team
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.